Evidence map›Paper›PMID 39868965›Full record

ArticleEmerging microbes & infections2025

Occurrence and clinical correlates of SARS-CoV-2 viremia in two German patient cohorts.

Katharina Grikscheit, Annemarie Berger, Holger Rabenau, Niko Kohmer, Katharina S Appel, Margarete Scherer, Robert Bals, Sabine Blaschke, Axel Hamprecht, Sina M Hopff and 12 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Emerging microbes & infections, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Katharina GrikscheitInstitute for Medical Virology, Goethe University, University Hospital Frankfurt, Frankfurt am Main, Germany.
Annemarie BergerInstitute for Medical Virology, Goethe University, University Hospital Frankfurt, Frankfurt am Main, Germany.
Holger RabenauInstitute for Medical Virology, Goethe University, University Hospital Frankfurt, Frankfurt am Main, Germany.
Niko KohmerInstitute for Medical Virology, Goethe University, University Hospital Frankfurt, Frankfurt am Main, Germany.
Katharina S AppelFaculty of Medicine, Institute for Digital Medicine and Clinical Data Science, Goethe University Frankfurt, Frankfurt am Main, Germany.
Margarete SchererFaculty of Medicine, Institute for Digital Medicine and Clinical Data Science, Goethe University Frankfurt, Frankfurt am Main, Germany.
Robert BalsDepartment of Internal Medicine V - Pulmonology, Infectious Diseases, Intensive Care Medicine, Saarland University, Homburg, Germany.
Sabine BlaschkeEmergency Department, University Medical Center Göttingen, Göttingen, Germany.
Axel HamprechtInstitute of Medical Microbiology and Virology, Carl von Ossietzky University Oldenburg, Oldenburg, Germany.
Sina M HopffFaculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.
Dagmar KreftingDepartment of Medical Informatics, University Medical Center Göttingen, Göttingen, Germany.
Patrick MeybohmDepartment of Anesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital Würzburg, Würzburg, Germany.
Carolin NürnbergerInstitute for Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany.
Peter HeuschmannInstitute for Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany.
Caitlin PleyDepartment of Infectious Diseases and Respiratory Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany.
Susana M Nunes de MirandaFaculty of Medicine and University Hospital Cologne, Department I for Internal Medicine, University of Cologne, Cologne, Germany.
Edgar DahlRWTH cBMB at the Institute of Pathology, Medical Faculty of RWTH Aachen University, Aachen, Germany.
Björn JensenDepartment of Gastroenterology, Hepatology and Infectious Diseases, Medical Faculty, Düsseldorf University Hospital, Heinrich Heine University, Düsseldorf, Germany.
Thomas IlligHannover Unified Biobank, Hannover Medical School, Hannover, Germany.
Gabriele AntonMedical School OWL, Bielefeld University, Bielefeld, Germany.
Jörg Janne VehreschildFaculty of Medicine, Institute for Digital Medicine and Clinical Data Science, Goethe University Frankfurt, Frankfurt am Main, Germany.
Sandra CiesekInstitute for Medical Virology, Goethe University, University Hospital Frankfurt, Frankfurt am Main, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Viremia defined as detectable SARS-CoV-2 RNA in the blood is a potential marker of disease severity and prognosis in COVID-19 patients. Here, we determined the frequency of viremia in serum of two independent COVID-19 patient cohorts within the German National Pandemic Cohort Network (German:

Indexed as

COVID-19SARS-CoV-2ViremiaAdultAgedAged, 80 and overAntibodies, NeutralizingAntibodies, ViralCohort StudiesCross-Sectional StudiesFemaleGermanyHumansMaleMiddle AgedRNA, ViralAntibodies, NeutralizingAntibodies, ViralRNA, ViralCOVID-19prospective national cohortSARS-CoV-2viremia

Identifiers

PMID39868965
PMCPMC11812106

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.